fashion -WSS

fashion

author：explore 2025-09-27 18:53:35 - browse：198

A group of four doctors gather around a hologram projecting different medical icons — health tech coverage from STAT — Adobe

DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental health company Twill for $10 million in cash plus stock valued at over $20 million at the end of Tuesday trading. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.

Founded in 2011, Dario started with a diabetes app targeted at consumers before expanding it to hypertension and weight management. It still maintains that direct-to-consumer business but has since shifted its focus to selling its suite of offerings, including a musculoskeletal care program it acquired in 2021, to health plans and employers in the hopes of reaching much larger patient populations. Recent updates aimed at making itself attractive to clients include a new offering built around popular, and expensive, GLP-1 weight loss drugs, and published real world data suggesting its tools can save clients money on downstream health care costs. With Twill, Dario adds a mental health app and related services, addressing a top demand of employers.

Despite momentum, DarioHealth, which is publicly traded, is unprofitable, and by its own estimations on earnings calls last year, it remained a ways from that milestone. Before acquiring Twill, the company said that it expected the whole business to break even at about $80 million in revenue — about four times the roughly $20 million it projected for 2023. In November, the company reported that it lost over $40 million in the first nine months of 2023.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Cigna, Humana reportedly in talks to merge

leisure time

WSS

Medicare Advantage's lean provider networks lead CMS complaints

Fetal surgery at risk from Dobbs and new abortion restrictions

What to do when lifesaving products contribute to climate change

Eli Lilly’s Zepbound improved liver scarring in mid

Finland to offer bird flu vaccine to select groups of people, a possible global first

Structure Therapeutics oral GLP

Wikipedia

fashion

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

Elevance PBM president out as customers face prescription chaos

The cancer drug shortage isn’t new — and neither are the solutions

An outdated Medicare rule harms dementia patients with anxiety

In Memoriam: Notable people who died in 2023

Eli Lilly’s Zepbound improved liver scarring in mid

Cancer drug shortages should be causing more outrage

The EPA's new lead rule: How one expert crunched the numbers

Moonlake's readout produced a cash windfall. Risks remain

How CO2 helps viruses stay alive longer in the air

leisure time

30 years of 'Listening to Prozac'

The EPA's new lead rule: How one expert crunched the numbers

Despite FDA concern, risk that CAR

Senators tussle over abortion against the backdrop of a presidential campaign

ReNAgade cuts staff seven months after raising $300 million

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

focus

leisure time

hotspot

explore